Multipharma
0866.855.346 · rovalta.com · 21/09/2026
ACTIVE
Multipharma
Financial year 2025 · closed on 31/12/2025
Net result
-2,9 M €
-248.7% YoY
Revenue
580,8 M €
+5.7% YoY
Equity
128,1 M €
+33.8% YoY
Workforce
1 522,8 ETP
+1.1% YoY
Overview
What does Multipharma do?
Multipharma is a Cooperative society incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht. It employs on average 1 522,8 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0866.855.346
Incorporation
19/08/2004
Legal form
Cooperative society
Registered office
Square Marie Curie 30
1070 Anderlecht · BruxellesSee on map
1070 Anderlecht · BruxellesSee on map
Contributed capital
104 262 664,00 €
Latest accounts
31/12/2025
Average workforce
1 522,8 ETP
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores52310Warehousing and support activities for transportation47120Retail sale in non-specialised stores47279Retail sale of food, beverages and tobacco in specialised stores47299Other retail sale of food in specialised stores+11
Joint committees (2)
- 313
- 321
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Revenue | 580,8 M € | +5.7% | 549,7 M € | +6.3% | 517,1 M € | +5.5% | 490,0 M € | +3.6% | 472,9 M € | +2.6% | 460,7 M € | +3.8% | 443,8 M € | -2.2% | 454,0 M € | +6.2% | 427,4 M € | – | 109,0 k € | – | – | – | – | – | – | – | |||||||||
| EBITDA | 10,8 M € | -4.0% | 11,2 M € | -14.7% | 13,2 M € | -35.5% | 20,4 M € | -5.2% | 21,6 M € | +48.7% | 14,5 M € | +81.3% | 8,0 M € | -40.0% | 13,3 M € | +168% | -19,5 M € | -138943540% | 14,0 € | -99.9% | 15,3 k € | -47.4% | 29,1 k € | -23.5% | 38,1 k € | -5.3% | 40,2 k € | +22.8% | 32,7 k € | -30.2% | 46,9 k € | -11.2% | 52,8 k € | -26.1% | 71,4 k € |
| Operating result | -250,4 k € | -117% | 1,5 M € | -40.5% | 2,4 M € | -74.5% | 9,6 M € | -17.4% | 11,6 M € | +291% | 3,0 M € | +236% | -2,2 M € | -134% | 6,3 M € | +118% | -34,2 M € | -244282218% | 14,0 € | -99.9% | 15,1 k € | +200% | -15,2 k € | -60.6% | -9,4 k € | -23.2% | -7,7 k € | +48.7% | -14,9 k € | -10804% | -137,0 € | -118% | 765,7 € | -96.0% | 19,4 k € |
| Net result | -2,9 M € | -249% | -819,2 k € | -215% | 712,9 k € | -85.8% | 5,0 M € | -30.1% | 7,2 M € | +151% | 2,9 M € | +148% | -6,0 M € | -320% | 2,7 M € | +105% | -50,8 M € | -5076172673% | 1,0 € | -100.0% | 12,7 k € | +147% | -26,9 k € | -77.2% | -15,2 k € | +0.2% | -15,2 k € | +32.8% | -22,6 k € | -152% | -9,0 k € | +2.4% | -9,2 k € | -213% | 8,2 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 128,1 M € | +33.8% | 95,7 M € | -0.8% | 96,5 M € | +0.6% | 96,0 M € | +6.1% | 90,4 M € | +9.0% | 83,0 M € | +3.7% | 80,0 M € | -5.9% | 85,0 M € | +10.7% | 76,8 M € | +7469% | 1,0 M € | +6593% | 15,2 k € | +504% | 2,5 k € | -91.5% | 29,4 k € | -34.0% | 44,6 k € | -25.4% | 59,8 k € | -27.5% | 82,4 k € | -9.8% | 91,4 k € | -9.1% | 100,6 k € |
| Total assets | 274,3 M € | +45.5% | 188,5 M € | -2.2% | 192,8 M € | -0.0% | 192,8 M € | +2.7% | 187,8 M € | +3.7% | 181,0 M € | +1.8% | 177,8 M € | -8.0% | 193,2 M € | +27.7% | 151,3 M € | +14740% | 1,0 M € | +4912% | 20,3 k € | -75.8% | 84,1 k € | -49.1% | 165,4 k € | -19.6% | 205,6 k € | -20.5% | 258,5 k € | -18.0% | 315,1 k € | -6.3% | 336,2 k € | -14.6% | 393,4 k € |
| Cash | 27,9 M € | +110% | 13,3 M € | -27.6% | 18,3 M € | -22.8% | 23,8 M € | +33.2% | 17,8 M € | +56.8% | 11,4 M € | +52.8% | 7,4 M € | -49.6% | 14,8 M € | +0.9% | 14,6 M € | +1338% | 1,0 M € | +8229% | 12,2 k € | +69.0% | 7,2 k € | -67.7% | 22,4 k € | +20.6% | 18,6 k € | -6.7% | 19,9 k € | +13.9% | 17,5 k € | -36.8% | 27,7 k € | -23.6% | 36,3 k € |
| Debts | 139,4 M € | +59.8% | 87,2 M € | -3.2% | 90,1 M € | +0.5% | 89,7 M € | -1.1% | 90,6 M € | -0.0% | 90,6 M € | +4.0% | 87,2 M € | -12.9% | 100,1 M € | +47.9% | 67,7 M € | +1528318% | 4,4 k € | -14.5% | 5,2 k € | -93.2% | 76,6 k € | -43.7% | 136,0 k € | -15.6% | 161,0 k € | -19.0% | 198,7 k € | -14.6% | 232,7 k € | -4.9% | 244,8 k € | -16.4% | 292,8 k € |
| Other | |||||||||||||||||||||||||||||||||||
| Workforce | 1 522,8 ETP | +1.1% | 1 505,8 ETP | -0.7% | 1 517,1 ETP | -0.9% | 1 531,1 ETP | +0.5% | 1 523,1 ETP | -1.8% | 1 551,5 ETP | -3.2% | 1 603,2 ETP | -1.3% | 1 624,6 ETP | +7.1% | 1 516,9 ETP | – | 0,6 ETP | -33.3% | 0,9 ETP | 0.0% | 0,9 ETP | 0.0% | 0,9 ETP | -18.2% | 1,1 ETP | 0.0% | 1,1 ETP | 0.0% | 1,1 ETP | 0.0% | 1,1 ETP | ||
Estimate
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 6 active · 34 ended
Active mandates
Jimmy SCHEVERNELS
ActiveJohan DEKENS
ActiveMartine MAGNEE
ActiveMichel LUTTGENS
ActiveGeert REYNIERS
ActiveHans HEYNDELS
ActiveEnded mandates
Francis COLARIS
EndedJimmy SCHEVERNELS
EndedJohan DEKENS
EndedMartine MAGNEE
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
Apoteek Jespers - Cuijpers● Active | 0440.256.175 |
APOTEEK P. Sergeant● Active | 0454.105.203 |
APOTHEEK VANDYCK● Active | 0458.570.666 |
APOTHEEK VUNCKX-PEETERS● Active | 0897.964.137 |
DE ZEVEN HOEKEN● Active | 0461.480.369 |
DLA● Active | 0639.768.151 |
Goed Aalter● Active | 0808.051.471 |
MULTIPHARMA GROUP● Active | 0401.995.516 |
| 0406.518.090 | |
Popelin Apotheken● Active | 1004.967.609 |
TALPA FARMA● Active | 0686.929.353 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/06/2026 | 23/06/2025 | 30/12/2024 | 02/08/2023 | 22/06/2022 | 11/08/2021 |
| General meeting | 11/06/2026 | 12/06/2025 | 13/06/2024 | 08/06/2023 | 09/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
23 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 11/06/2026 | 25/06/2026 | French | |
| Full model | 31/12/2024 | 12/06/2025 | 23/06/2025 | French | |
| Full modelCorrection | 31/12/2023 | 13/06/2024 | 30/12/2024 | French | |
| Full model | 31/12/2023 | 13/06/2024 | 17/07/2024 | French | |
| Full model | 31/12/2022 | 08/06/2023 | 02/08/2023 | French | |
| Full model | 31/12/2021 | 09/06/2022 | 22/06/2022 | French | |
| Full model | 31/12/2020 | 10/06/2021 | 11/08/2021 | French | |
| Full modelCorrection | 31/12/2019 | 11/06/2020 | 27/10/2020 | French | |
| Full model | 31/12/2019 | 11/06/2020 | 02/07/2020 | French | |
| Full modelCorrection | 31/12/2018 | 13/06/2019 | 27/08/2019 | French | |
| Full model | 31/12/2018 | 13/06/2019 | 27/06/2019 | French | |
| Full model | 31/12/2017 | 14/06/2018 | 13/07/2018 | French | |
| Full model | 31/12/2016 | 08/06/2017 | 20/06/2017 | French | |
| Full model | 31/12/2015 | 09/06/2016 | 16/06/2016 | French | |
| Full model | 30/06/2015 | 07/10/2015 | 20/10/2015 | French | |
| Abridged model | 30/06/2014 | 01/08/2014 | 11/08/2014 | French | |
| Abridged model | 30/06/2013 | 07/12/2013 | 10/12/2013 | French | |
| Abridged model | 30/06/2012 | 01/12/2012 | 03/12/2012 | French | |
| Abridged model | 30/06/2011 | 16/12/2011 | 04/01/2012 | French | |
| Abridged model | 30/06/2010 | 04/12/2010 | 06/12/2010 | French | |
| Abridged model | 30/06/2009 | 05/12/2009 | 07/12/2009 | French | |
| Abridged model | 30/06/2008 | 06/12/2008 | 08/12/2008 | French | |
| Abridged model | 30/06/2007 | 01/12/2007 | 13/12/2007 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 6 active · 34 ended
Active mandates
Jimmy SCHEVERNELS
ActiveJohan DEKENS
ActiveMartine MAGNEE
ActiveMichel LUTTGENS
ActiveGeert REYNIERS
ActiveHans HEYNDELS
ActiveEnded mandates
Francis COLARIS
EndedJimmy SCHEVERNELS
EndedJohan DEKENS
EndedMartine MAGNEE
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates23/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates23/06/2026DEMISSIONS, NOMINATIONS
- Restructuring21/10/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring21/10/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring26/08/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
- Restructuring26/08/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates03/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates03/07/2025DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-2,9 M €↓
- 12/06/2025nominationMichel LÜTTGENS — administrateur
- 12/06/2025reconductionMartine MAGNEE — administrateur
- 12/06/2025reconductionJohan DEKENS — administrateur
- 12/06/2025reconductionJimmy SCHEVERNELS — administrateur
- 12/06/2025reconductionKPMG Réviseurs d'Entreprises SRL — Commissaire
- 12/06/2025nominationMichel LÜTTGENS — bestuurder
- 12/06/2025reconductionMartine MAGNEE — bestuurder
- 12/06/2025reconductionJohan DEKENS — bestuurder
- 12/06/2025reconductionJimmy SCHEVERNELS — bestuurder
- 12/06/2025reconductionKPMG Bedrijfsrevisoren BV — commissaris
- 04/02/2025nominationGeert REYNIERS — Gedelegeerd bestuurder
- 04/02/2025nominationAlain BOGAERT — mandataris (Finance & Administration Directeur)
- 04/02/2025nominationCindy DEWITTE — mandataris (Human Resources Directeur)
- 04/02/2025nominationJean MAGGIORDOMO — mandataris (Pharmacy Operations Directeur)
- 04/02/2025nominationRiad BELGUENANI — mandataris
- 04/02/2025nominationGrégory STENMANS — mandataris
- 04/02/2025nominationJean VANDENBUSSCHE — mandataris
- 2024Annual accounts 2024-819,2 k €↓
- 24/10/2024nominationDelphine HAHAJI — membre du Comité de direction
- 24/10/2024nominationDelphine HAJAJI — lid van het directiecomité
- 13/06/2024reconductionGeert REYNIERS — bestuurder
- 13/06/2024reconductionHans HEYNDELS — bestuurder
- 13/06/2024reconductionGeert REYNIERS — administrateur
- 13/06/2024reconductionHans HEYNDELS — administrateur
- 01/01/2024reconductionGeert REYNIERS — Administrateur délégué
- 01/01/2024nominationFrancis COLARIS — Président du Conseil d'administration
- 2023Annual accounts 2023712,9 k €↓
- 19/10/2023nominationGeert REYNIERS — Administrateur délégué
- 19/10/2023nominationAlain BOGAERT — Mandataire
- 19/10/2023nominationCindy DEWITTE — Mandataire
- 19/10/2023nominationJean MAGGIORDOMO — Mandataire
- 19/10/2023nominationRiad BELGUENANI — Mandataire
- 19/10/2023nominationGrégory STENMANS — Mandataire
- 19/10/2023nominationRomain COLA — Mandataire
- 19/10/2023nominationGeert REYNIERS — Gedelegeerd bestuurder
- 19/10/2023nominationAlain BOGAERT — Mandataris
- 19/10/2023nominationCindy DEWITTE — Mandataris
- 19/10/2023nominationJean MAGGIORDOMO — Mandataris
- 19/10/2023nominationRiad BELGUENANI — Mandataris
- 19/10/2023nominationGrégory STENMANS — Mandataris
- 19/10/2023nominationRomain COLA — Mandataris
- 08/06/2023nominationGeert REYNIERS — Gedelegeerd bestuurder
- 08/06/2023nominationAlain BOGAERT — Mandataris
- 08/06/2023nominationCindy DEWITTE — Mandataris
- 08/06/2023nominationJean MAGGIORDOMO — Mandataris
- 08/06/2023nominationRiad BELGUENANI — Mandataris
- 08/06/2023nominationGrégory STENMANS — Mandataris
- 08/06/2023nominationPascale TRICOT — Mandataris
- 08/06/2023nominationGeert REYNIERS — Administrateur délégué
- 08/06/2023nominationAlain BOGAERT — Mandataire
- 08/06/2023nominationCindy DEWITTE — Mandataire
- 08/06/2023nominationJean MAGGIORDOMO — Mandataire
- 08/06/2023nominationRiad BELGUENANI — Mandataire
- 08/06/2023nominationGrégory STENMANS — Mandataire
- 08/06/2023nominationPascale TRICOT — Mandataire
- 06/04/2023nominationGeert REYNIERS — Gedelegeerd bestuurder
- 06/04/2023nominationAlain BOGAERT — Mandataris
- 06/04/2023nominationCindy DEWITTE — Mandataris
- 06/04/2023nominationJean MAGGIORDOMO — Mandataris
- 06/04/2023nominationNisrine BOUCHRIT — Mandataris
- 06/04/2023nominationGrégory STENMANS — Mandataris
- 06/04/2023nominationPascale TRICOT — Mandataris
- 06/04/2023nominationGeert REYNIERS — Administrateur délégué
- 06/04/2023nominationAlain BOGAERT — Mandataire
- 06/04/2023nominationCindy DEWITTE — Mandataire
- 06/04/2023nominationJean MAGGIORDOMO — Mandataire
- 06/04/2023nominationNisrine BOUCHRIT — Mandataire
- 06/04/2023nominationGrégory STENMANS — Mandataire
- 06/04/2023nominationPascale TRICOT — Mandataire
- 2022Annual accounts 20225,0 M €↓
- 09/06/2022reconductionFrancis COLARIS — bestuurder
- 09/06/2022reconductionJohan DEKENS — bestuurder
- 09/06/2022reconductionMartine MAGNEE — bestuurder
- 09/06/2022reconductionJimmy SCHEVERNELS — bestuurder
- 09/06/2022nominationAxel Jorion — commissaris (vaste vertegenwoordiger)
- 09/06/2022reconductionFrancis COLARIS — administrateur
- 09/06/2022reconductionJohan DEKENS — administrateur
- 09/06/2022reconductionMartine MAGNEE — administrateur
- 09/06/2022reconductionJimmy SCHEVERNELS — administrateur
- 09/06/2022nominationKPMG Réviseurs d Entreprises SRL — Commissaire
- 24/03/2022nominationGeert REYNIERS — Administrateur délégué
- 24/03/2022nominationAlain BOGAERT — Mandataire
- 24/03/2022nominationCindy DEWITTE — Mandataire
- 24/03/2022nominationJean MAGGIORDOMO — Mandataire
- 24/03/2022nominationIsmaël BOLSONI SIBILA — Mandataire
- 24/03/2022nominationGrégory STENMANS — Mandataire
- 24/03/2022nominationPascale TRICOT — Mandataire
- 24/03/2022nominationGeert REYNIERS — Bestuurder
- 24/03/2022nominationAlain BOGAERT — Mandataris
- 24/03/2022nominationCindy DEWITTE — Mandataris
- 24/03/2022nominationJean MAGGIORDOMO — Mandataris
- 24/03/2022nominationIsmaël BOLSONI SIBILA — Mandataris
- 24/03/2022nominationGrégory STENMANS — Mandataris
- 24/03/2022nominationPascale TRICOT — Mandataris
- 2021Annual accounts 20217,2 M €↑
- 2020Annual accounts 20202,9 M €↑
- 2019Annual accounts 2019-6,0 M €↓
- 2018Annual accounts 20182,7 M €↑
- 2017Annual accounts 2017-50,8 M €↓
- 2015Annual accounts 20151,0 €↓
- 2015Annual accounts 201512,7 k €↑
- 2015Name changeMULTIPHARMA
- 2014Annual accounts 2014-26,9 k €↓
- 2013Annual accounts 2013-15,2 k €↑
- 2012Annual accounts 2012-15,2 k €↑
- 2011Annual accounts 2011-22,6 k €↓
- 2010Annual accounts 2010-9,0 k €↑
- 2009Annual accounts 2009-9,2 k €↓
- 2008Annual accounts 20088,2 k €
- 2008Name changePHARMACIE GRANDJEAN
- 19/08/2004IncorporationCooperative society